Levothyroxine (Synthroid): How It Works, Dosage, TSH Targets and Complete Hypothyroidism Guide 2026
Levothyroxine is the third most prescribed medication in the United States — with over 102 million prescriptions written annually — and one of the most consistently misunderstood. Sold under brand names including Synthroid, Levoxyl, Tirosint, and Unithroid, and available as an inexpensive generic, levothyroxine is the standard treatment for hypothyroidism — a condition where the thyroid gland does not produce enough thyroid hormone. It is also one of the few medications where tiny differences in how and when it is taken — empty stomach versus with food, 30 minutes before breakfast versus at the same time as calcium or iron supplements — can substantially affect how much of the drug actually reaches the bloodstream and does its job.
Hypothyroidism affects approximately 5% of the US population — with subclinical hypothyroidism (mildly elevated TSH with normal thyroid hormone levels) affecting another 5–10%. One in eight women will develop a thyroid disorder during her lifetime. The thyroid — a small butterfly-shaped gland in the front of the neck — is responsible for producing hormones that regulate virtually every major metabolic process in the body: heart rate, body temperature, energy metabolism, brain function, growth, reproductive health, and cholesterol metabolism. When thyroid hormone production fails, every system is affected.
This complete 2026 guide covers what hypothyroidism is and how it is diagnosed, what levothyroxine is and why it is the treatment of choice, the critical morning fasting timing rule and exactly what can and cannot be taken near it, correct dosing by patient group including the pregnancy dose increase rule, the TSH monitoring schedule and target ranges, the all-important black box warning that levothyroxine is not for weight loss, what happens when levothyroxine is overdosed or undertreated, and the Synthroid versus generic levothyroxine debate finally resolved.
The FDA's updated May 2026 prescribing information for levothyroxine (LEVO-T) is available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/021342s028lbl.pdf
What is Hypothyroidism? — The Thyroid and Why It Matters
The thyroid gland is a small, butterfly-shaped organ located in the front of the neck, just below the Adam's apple. Despite its small size, it controls some of the most fundamental processes in human physiology by producing two primary hormones:
Thyroxine (T4) — the storage form; produced in large quantities and converted to the active form in peripheral tissues
Triiodothyronine (T3) — the biologically active form; converted from T4 in the liver, kidney, and other tissues; binds to thyroid hormone receptors throughout the body
What thyroid hormones control:
Thyroid hormone receptors are present in virtually every cell in the body. T3 regulates:
Basal metabolic rate — the rate at which the body burns calories at rest
Heart rate and cardiac output
Body temperature and heat generation
Brain development and cognitive function
Cholesterol metabolism — hypothyroidism causes elevated LDL cholesterol
Reproductive hormone function — hypothyroidism disrupts menstrual cycles and fertility
Muscle and nerve function — including reflexes and gut motility (explains constipation in hypothyroidism)
How TSH regulates the thyroid — the feedback loop:
The hypothalamus releases thyrotropin-releasing hormone (TRH) → which signals the pituitary gland to release thyroid-stimulating hormone (TSH) → TSH stimulates the thyroid to produce T4 and T3. When thyroid hormone levels are adequate, the pituitary reduces TSH secretion (negative feedback). When thyroid hormone is low, TSH rises to try to drive more hormone production.
This is why TSH is used to diagnose and monitor hypothyroidism — it is the pituitary's sensitive readout of thyroid hormone status throughout the body. A high TSH means the body is not getting enough thyroid hormone and is demanding more.
Types of hypothyroidism:
Primary hypothyroidism — the thyroid gland itself fails; by far the most common type (>95% of cases); TSH elevated; T4 low
Secondary hypothyroidism — the pituitary fails to produce TSH; TSH low or normal; T4 low; rare; TSH cannot be used to guide levothyroxine dosing in this case
Tertiary hypothyroidism — hypothalamic failure; TRH deficiency; extremely rare
Hashimoto's thyroiditis — the most common cause of primary hypothyroidism in the USA; autoimmune destruction of the thyroid gland; anti-TPO antibodies positive; often presents with a period of hyperthyroidism (Hashitoxicosis) before hypothyroidism develops
Symptoms of Hypothyroidism — Why It Is So Often Missed
Hypothyroidism is notoriously difficult to recognise because its symptoms are non-specific and develop gradually — often attributed to stress, ageing, depression, or overwork for years before diagnosis:
Common symptoms:
Fatigue and lethargy — the most universal symptom; profound, disproportionate to activity; differs from tiredness after exertion
Weight gain — even without increase in food intake; due to slowed metabolism; typically 5–10kg over months to years
Cold intolerance — feeling cold when others are comfortable; reduced heat generation
Constipation — slowed gut motility from reduced thyroid hormone effect on intestinal smooth muscle
Dry skin, dry hair, and hair loss — reduced cell turnover; hair becomes brittle; thinning across the scalp and outer eyebrows (the classic outer third eyebrow loss sign)
Bradycardia — slow heart rate; sometimes below 60 bpm
Elevated LDL cholesterol — thyroid hormone is required for normal LDL receptor function; hypothyroidism causes secondary hypercholesterolaemia
Depression and cognitive slowing — "brain fog"; poor memory; depressed mood
Menstrual irregularities — heavy periods, irregular cycles, infertility
Myxoedema — in severe cases: non-pitting oedema particularly of the face, hands, and lower legs; periorbital puffiness (puffiness around the eyes); thickened, doughy facial features
Hoarse voice — fluid accumulation around the vocal cords
Muscle weakness and cramps
Elevated CK (creatine kinase) — from muscular hypothyroid changes; can mimic statin myopathy
Diagnosis — blood tests:
TSH (thyroid-stimulating hormone): the first-line screening test; elevated in primary hypothyroidism; normal range 0.4–4.0 mIU/L
Free T4 (FT4): the level of circulating active thyroxine; low in overt hypothyroidism; may be normal in subclinical hypothyroidism (where only TSH is elevated)
Anti-TPO antibodies: positive in Hashimoto's thyroiditis — identifies the autoimmune cause but does not change initial management
What is Levothyroxine? — The Drug
Levothyroxine sodium is the synthetic, pharmaceutical-grade form of the T4 (thyroxine) that the healthy thyroid gland would normally produce. It is bioidentical to endogenous human T4 — the same molecule.
After oral ingestion, levothyroxine is absorbed from the small intestine, enters the bloodstream bound to thyroid binding proteins (TBG), and is converted in peripheral tissues (liver, kidney, muscle) to T3 — the biologically active form that enters cells and binds to thyroid hormone receptors. This conversion step is why levothyroxine therapy restores normal thyroid hormone function throughout the body.
Why levothyroxine rather than T3 (liothyronine):
Most patients are treated with T4 (levothyroxine) alone — not T3 — because:
T4 has a long half-life of approximately 7 days, allowing once-daily dosing with stable blood levels
The body's own T3/T4 ratio is maintained by peripheral conversion — providing individualised, tissue-appropriate T3 delivery
Liothyronine (synthetic T3) has a short half-life of 18–24 hours, causing peaks and troughs that can produce palpitations, anxiety, and cardiovascular strain
Some patients — particularly those who have had total thyroidectomy or feel persistently unwell on T4 alone — may benefit from combination T4+T3 therapy under endocrinologist supervision
The Black Box Warning — Levothyroxine Is NOT for Weight Loss
This is the first and most important safety message in levothyroxine prescribing: there is an FDA black box warning explicitly stating that levothyroxine must NOT be used for weight loss or obesity treatment in patients with normal thyroid function (euthyroid patients).
In euthyroid patients — those who produce adequate thyroid hormone — administering levothyroxine does not produce sustained weight loss. It induces iatrogenic (drug-caused) hyperthyroidism, which produces muscle breakdown (not fat loss), cardiac arrhythmias, accelerated bone loss (osteoporosis), and potentially life-threatening cardiovascular complications including atrial fibrillation and heart attack.
The black box warning applies to using levothyroxine for weight loss. Patients who have genuine hypothyroidism and are treated to normal TSH will often lose some of the weight gained during their hypothyroid period — but this is restoration of normal metabolic function, not a pharmacological weight loss effect.
Dosage — Complete Guide
Full replacement dose formula:
The standard full replacement dose of levothyroxine for adults with primary hypothyroidism is approximately 1.6 mcg per kilogram of body weight per day. For example: a 70kg adult requires approximately 112 mcg daily; an 80kg adult approximately 125 mcg daily.
Starting doses — by patient group:
Patient Group | Starting Dose | Titration | Goal |
Young healthy adult (under 50, no cardiac disease) | 75–100 mcg daily OR 1.6 mcg/kg/day directly | Every 4–6 weeks based on TSH | TSH within normal range (0.4–4.0 mIU/L) |
Adult over 50 OR cardiac history | 25–50 mcg daily | Increase by 12.5–25 mcg every 4–6 weeks | Same TSH target — slower titration prevents cardiac stress |
Severe or long-standing hypothyroidism | 25 mcg daily | Very slow escalation every 2–4 weeks | Avoid too-rapid correction — risk of precipitating angina or arrhythmia |
Pregnancy (known hypothyroid) | Increase dose by 25–30% immediately on confirmation | TSH monitored every 4 weeks | TSH below 2.5 mIU/L in first trimester; below 3.0 in second/third |
Elderly (65+) | 25–50 mcg; increase to 1.0 mcg/kg/day target | Slow escalation every 4–6 weeks | TSH may be targeted at upper-normal range (1–4 mIU/L) |
Post-thyroidectomy (thyroid cancer) | Full replacement + possible TSH suppression | TSH target depends on cancer risk | High-risk cancer: TSH suppressed below 0.1 mIU/L; low-risk: low-normal |
TSH monitoring schedule:
At 6–8 weeks after starting or changing dose — TSH has a half-life that means it takes 4–6 weeks to equilibrate after a dose change
Once stable: annually for most patients
More frequent monitoring: in pregnancy (every 4 weeks throughout); after any significant body weight change; after starting or stopping interacting medications; after switching between brand and generic preparations
The Morning Fasting Rule — The Most Critical Practical Instruction
The single most important practical fact about levothyroxine that directly affects treatment outcomes: it must be taken on an empty stomach.
Correct administration:
Take levothyroxine 30–60 minutes before breakfast on an empty stomach
Take with a full glass of water — levothyroxine tablets can disintegrate rapidly and partial absorption occurs
Do NOT take with coffee — coffee significantly reduces levothyroxine absorption even when taken simultaneously or within 30 minutes; wait 30–60 minutes after levothyroxine before drinking coffee
Do NOT take within 4 hours of calcium supplements, antacids containing calcium or aluminium, iron supplements, multivitamins with minerals, or cholestyramine/colestipol (bile acid sequestrants) — these form insoluble complexes with levothyroxine, dramatically reducing absorption
Why fasting matters — the absorption science:
Levothyroxine bioavailability on an empty stomach is approximately 70–80%. With food — particularly high-fibre foods, soy products, or dairy — it can fall to 40–50%. This difference between 80% and 50% absorption at the same dose means some patients may effectively be chronically undertreated without realising it. Consistently taking levothyroxine with food or within 30 minutes of coffee can produce a TSH that appears treatment-resistant while the issue is purely one of inconsistent absorption.
Alternative timing — the bedtime option:
For patients who cannot reliably take levothyroxine 30–60 minutes before breakfast — which requires waking up early or delaying the morning coffee routine — consistent bedtime administration (at least 3 hours after the last meal and 4 hours away from supplements) is an evidence-based alternative that produces equivalent or marginally better TSH normalisation than morning dosing in some studies. Consistency of timing is more important than morning versus bedtime — the worst outcome is alternating between the two.
Critical Drug and Food Interactions
Substance | Effect on Levothyroxine | Time Separation Required |
Coffee (including decaf) | Reduces absorption significantly | 30–60 minutes after levothyroxine |
Calcium supplements | Forms insoluble complex — reduces absorption by 20–40% | Minimum 4 hours after levothyroxine |
Iron supplements (ferrous sulfate) | Reduces absorption by up to 40% | Minimum 4 hours after levothyroxine |
Antacids (calcium carbonate, aluminium hydroxide, magnesium) | Chelation — reduces absorption | Minimum 4 hours after levothyroxine |
Multivitamins with minerals | Combined calcium/iron effect | Minimum 4 hours after levothyroxine |
Cholestyramine / colestipol (bile acid sequestrants) | Binds T4 in the gut — major reduction | Minimum 4–6 hours after levothyroxine |
Proton pump inhibitors (omeprazole, pantoprazole) | Reduces gastric acid needed for dissolution | Monitor TSH; may need dose adjustment |
Soy products (soy milk, tofu) | Reduces absorption | Avoid within 1 hour of levothyroxine |
High-fibre foods | Reduces absorption | Avoid taking with high-fibre foods |
Warfarin | Levothyroxine increases warfarin sensitivity — increased bleeding risk | Monitor INR carefully when starting/adjusting levothyroxine |
Digoxin | Levothyroxine may reduce digoxin levels | Monitor digoxin levels |
Antiepileptics (phenytoin, carbamazepine) | Increase levothyroxine metabolism — may need higher doses | Monitor TSH; dose adjustment may be required |
Signs of Overdose (Too Much Levothyroxine) vs Underdose
Recognising over- and under-treatment is essential because both have significant health consequences:
Signs of overtreatment (iatrogenic hyperthyroidism — TSH too low):
Palpitations, rapid heart rate, atrial fibrillation
Anxiety, nervousness, irritability, insomnia
Heat intolerance and excessive sweating
Tremor of the hands
Weight loss despite normal appetite
Diarrhoea
Bone loss — accelerated osteoporosis with chronic over-treatment; post-menopausal women at particular risk
In severe overdose: chest pain, arrhythmia, thyroid storm — medical emergency
Signs of undertreatment (inadequate replacement — TSH too high):
All the original hypothyroid symptoms persist or worsen: fatigue, weight gain, cold intolerance, constipation, depression, cognitive slowing, hair loss, elevated cholesterol
The most dangerous consequence of severe, prolonged hypothyroidism: myxoedema coma — a life-threatening emergency characterised by hypothermia, loss of consciousness, respiratory failure, and haemodynamic instability. It is rare but fatal without emergency IV T4 (and often T3) therapy, intensive care, and treatment of underlying precipitating factors.
For our guide on thyroid disorders — the broader context of hyperthyroidism, Graves' disease, and thyroid nodules: [Thyroid Disorders: Hypothyroidism, Hyperthyroidism and Treatment Guide]
For our guide on high cholesterol / atorvastatin — hypothyroidism causes secondary hypercholesterolaemia; TSH should always be checked before starting a statin in a patient with elevated LDL; correcting hypothyroidism may normalise cholesterol without requiring statins: [Atorvastatin (Lipitor): Complete Statin Guide 2026]
For our guide on anxiety — levothyroxine overtreatment commonly causes anxiety symptoms; and undiagnosed hypothyroidism can cause depression misattributed to a primary mood disorder: [Anxiety Disorders: Types, Symptoms, Causes and Treatment]
The American Thyroid Association provides comprehensive patient resources on hypothyroidism diagnosis and treatment at: https://www.thyroid.org/hypothyroidism/
MedlinePlus provides patient information on levothyroxine at: https://medlineplus.gov/druginfo/meds/a682461.html
Frequently Asked Questions
What is levothyroxine used for and who needs it?
Levothyroxine is used to treat hypothyroidism — a condition where the thyroid gland does not produce enough thyroid hormone. Without adequate thyroid hormone, virtually every organ system is affected: metabolism slows causing weight gain and fatigue; the heart slows; the brain fogs; cholesterol rises; reproductive function is impaired. It is the third most prescribed medication in the USA with over 102 million prescriptions annually. The most common cause of hypothyroidism requiring levothyroxine is Hashimoto's thyroiditis — an autoimmune condition where the immune system destroys thyroid tissue. Levothyroxine is also used after thyroid surgery or radioiodine treatment, and to suppress TSH in thyroid cancer management.
Why must levothyroxine be taken on an empty stomach?
Levothyroxine absorption from the gut is highly dependent on an empty stomach and adequate gastric acid. When taken with food — particularly high-fibre foods, soy products, or dairy — bioavailability falls from approximately 70–80% to 40–50%. Coffee taken within 30 minutes of levothyroxine also significantly reduces absorption. Calcium supplements, iron tablets, and antacids must be separated by at least 4 hours as they form insoluble complexes with levothyroxine in the gut, preventing its absorption. The correct instruction: take levothyroxine with a full glass of water 30–60 minutes before breakfast, then wait before coffee. Consistency of timing every day is critical — alternating between fasting and non-fasting dosing causes TSH to fluctuate and makes dose adjustment unreliable.
How long does it take for levothyroxine to work?
Levothyroxine has a half-life of approximately 7 days, meaning it takes 4–6 weeks for blood levels to reach a new steady state after starting or changing the dose. TSH — the monitoring test — also takes 4–6 weeks to reflect the new steady-state levothyroxine level. This is why TSH should not be rechecked sooner than 6 weeks after any dose change. Clinically, most patients notice improvement in symptoms within 2–4 weeks of starting appropriate levothyroxine therapy, with full symptom resolution typically within 3–6 months. Some symptoms — particularly hair loss — may take longer to reverse.
Can levothyroxine cause weight loss?
An FDA black box warning explicitly prohibits the use of levothyroxine for weight loss or obesity treatment in people with normal thyroid function. In people with genuine hypothyroidism, restoring thyroid hormone to normal with levothyroxine often produces modest weight loss — typically 5–10% of body weight gained during the hypothyroid period — as the metabolic rate normalises. This is not a pharmacological weight loss effect; it is correction of the metabolic suppression caused by thyroid failure. In euthyroid patients, levothyroxine causes iatrogenic hyperthyroidism — muscle breakdown, cardiac arrhythmias, bone loss, and cardiovascular risk — not sustained fat loss.
Is generic levothyroxine as good as Synthroid?
Generic levothyroxine meets FDA bioequivalence standards and is clinically effective for most patients. However, the FDA has acknowledged that different formulations of levothyroxine — even those meeting bioequivalence standards — can produce small but clinically meaningful differences in TSH in some patients. For this reason, the Endocrine Society, American Thyroid Association, and American Association of Clinical Endocrinologists recommend that once a patient is stable on a specific preparation (brand or generic), they should not be automatically switched without TSH monitoring. Patients who are switched — whether from brand to generic or between generic manufacturers — should have their TSH rechecked 6 weeks after the change. Tirosint (liquid-filled capsule levothyroxine) is the most bioavailable formulation and may be preferred for patients with malabsorption syndromes.
Comments